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Introduction: Population monitoring and screening of blood pressure is an important part of any population
healthstrategy.Qualified healthworkersareexpensiveandoftenunavailableforscreening.Non-healthworkers
with electronic blood pressure monitors are increasingly used in community-based research. This approach is
unvalidated. In a poor, urban community we compared blood pressure measurements taken by non-health
workers using electronic devices against qualified health workers using mercury sphygmomanometers.
Method: Fifty-six adult volunteers participated in the research. Data were collected by five qualified health
workers, and six non-health workers. Participants were randomly allocated to have their blood pressure
measured on four consecutive occasions by alternating a qualified health worker with a non-health worker.
Descriptive statistics and graphs, and mixed effects linear models to account for the repeated measurement
were used in the analysis.
Results: Blood pressure readings by non-health workers were more reliable than those taken by qualified
health workers. Therewas no significant difference between the readings taken by qualified health workers and
those taken by non-health workers for systolic blood pressure. Non-health workers were, on average, 57
mmHg lowerin their measures of blood pressure than the qualified health workers (95%HPD: 2.9 to 10.0)
for diastolic blood pressure.
Conclusion: The results provide empirical evidence that supports the practice of non-health workers using
electronic devices for BP measurement in community-based research and screening. Non-health workers
recordedblood pressures that differedfrom qualified health workers byno more than 10 mmHg. The approach
is promising, but more research is needed to establish the generalisability of the results.
Keywords: blood pressure; hypertension; measurement; community workers; screening; Malaysia
Received: 29 January 2012; Revised: 14 April 2012; Accepted: 18 May 2012; Published: 27 June 2012
T
he substantial and growing burden of non-
communicable diseases (1), many of which are
associated with hypertension, has necessitated
population-based strategies for monitoring and screening
blood pressure (2, 3). Population studies, such as the
NHANES III and the Health Survey for England used
health professionals to obtain blood pressure readings
(411); with some professionals using mercury sphygmo-
manometers (12)  the gold standard for the indirect,
non-invasive, measurement of blood pressure (13)  and
some using electronic devices (14). Health care profes-
sionals, however, add significantly to the cost of health
research and screening programmes, and in many settings
(particularly resource-poor communities) there simply are
not the professionals available (15). Given the lack of
capacity, it is important to explore the use of community-
based, non-health workers as a replacement.
One possible impediment to non-health workers is that
mercury sphygmomanometers require significant train-
ing, but electronic monitors do provide an obvious
alternative (16). The use of electronic monitors by non-
health workers is not new (1719), but the approach does
not appear to have been validated. One recent study using
non-health workers cited a systematic review of electronic
blood pressure devices to underscore the validity of their
approach (18). Significantly, however, the review was of
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using qualified health care professionals (20, 21). Several
other studies that discuss validation in community
settings also used qualified health staff, often in a clinical
setting (2225).
The problem is that the sources of error in the
measurement of blood pressure are attributable to both
the device and the operator (16, 26). It is, thus, not
sufficient to validate the device alone, one needs to
validate the combination of the device and the operator,
but this is almost never done (2631). If the reliability and
validity of blood pressure measurement in a community
setting using non-health workers can be established
empirically, this will have significant implications for
future population health research; if not, the results will
throw into doubt a large number of existing studies.
The broad question motivating this research was
whether, under the same conditions in a community
setting, non-health workers using an electronic device
would on average obtain a diastolic and a systolic blood
pressure reading within 10 mmHg of a qualified health
professional using a mercury sphygmomanometer. A
variation of 10 mmHg may be unacceptable in a clinical
setting (32), although such variations are probably quite
common (33), but for the purposes of population health
screening and research, this was regarded as adequate.
Methods
Devices
Blood pressure was measured using mercury sphygmo-
manometers (Spirit brand, model number CK-101C),
and electronic, automatic blood pressure monitors (Om-
ron brand model HEM-7203). The electronic devices
used pulse wave oscillometry and a proprietary algorithm
to estimate blood pressure.
Setting
The data collection occurred in an urban, low-income
community, of the Klang Valley near Kuala Lumpur,
Malaysia.
Data collectors
Five medical practitioners with regular, current clinical
experience measuring blood pressure using mercury
sphygmomanometers were used as the health profes-
sionals in this study.
A non-health worker was categorized as an individual
with a minimum of a high school education and no
formal qualification in a health related profession.
The non-health workers in this study were five volunteer
medical students, three weeks into their first semester of
enrolment, and without any exposure to clinical practice.
Four of the students had no previous experience of blood
pressure monitoring; one had used an electronic blood
pressure device at home. The non-health workers received
30 min training in the use of the electronic device. The
training was significantly less than the two weeks
‘familiarisation’ typically allowed in clinical validation
studies (34), but more realistic in terms of population
health studies.
One of the non-health workers was called away part
way through data collection. He was replaced by a
research assistant who had no prior experience taking
blood pressure, but had been present during the training
of the non-health workers. He received a 10 min
‘refresher’ tutorial.
Participants
Participants were volunteers attending a local community
health event. Following the NHANES III protocol, the
exclusion criteria were rash, plaster casts, oedema,
paralysis, open sores or wounds, blood drawn from arm
within the last week, a withered arm, or physical
obstructions (such as tubes) (35). Seventy adults volun-
teered; 14 were excluded because their arm circumfer-
ences were greater than the upper limit for the electronic
devices’ cuff size. Of the remaining 56 participants, there
were 15 males ranging in age from 23 to 59, and 41
females ranging in age from 18 to 74.
Procedure
Data collection occurred over a 4-hour period starting at
11 am on a single day. Individual blood pressure
measurement commenced after the person had given
informed consent, the inclusion criteria were satisfied,
and personal information was obtained. Data were
recorded on age, sex, whether the participant was
pregnant (for women), had a known history of diabetes
or a known history of hypertension.
Each participant had their blood pressure measured
eight times in total. The order of measurement was
always twice by a randomly allocated medical practi-
tioner with their own allocated mercury sphygmoman-
ometer (T1), twice by a randomly allocated non-health
worker with their own allocated electronic device (T2),
twice by a second randomly allocated medical practi-
tioner with their own allocated mercury sphygmoman-
ometer (T3), and finally twice by a randomly allocated
non-health worker with their own allocated electronic
device (T4). Because data collectors were randomly
allocated to each participant ID prior to the commence-
ment of the study, by chance, some data collectors
conducted more blood pressure measures than others.
Diastolic and systolic blood pressures were recorded
twice by each data collector, on the left arm only. Between
30 seconds and 1 min elapsed between repeated measure-
ments to minimize venous congestion. Participants were
seated to wait for the next allocated data collector on the
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collectors in the allocated order.
Each data collector was allocated their own device
(mercury or electronic) for the entire data collection
period, and was blind to the readings of the other data
collectors. Participants were blind to all readings.
Data analysis
Data collectors recorded two systolic and two diastolic
readings for each participant. For the purposes of
analysis, a data collector’s diastolic readings were aver-
aged, as were the systolic readings. The distribution of
blood pressure readings were examined for normality.
The distribution of systolic blood pressure was signifi-
cantly non-normal, and log transformed for the purposes
of statistical modelling.
The data were initially examined using graphical
techniques including BlandAltman plots to contrast
two measurement instruments (36). The statistical mod-
elling employed two-level, linear mixed effects models in
which the blood pressure readings were treated as a
repeated measure (level-1), within participant (level-2)
(37). The order in which the testing occurred (which also
subsumed the type of device used, and the qualification
of the data collector) was included as a fixed factor
(having discounted the value of including it as a crossed
random factor). The models were ‘random intercepts’
models. Effects of age, sex, and clinical history (hyperten-
sion or diabetes) were included as fixed covariates in the
modelling. Age was centred on the median (49 years).
For the diastolic and the (log) systolic blood pressures,
three models were fitted:
1. A null (unconditional means) model with no fixed
effects, and participant as a random effect.
2. A full model with the order of measurement and age,
sex, hypertension and diabetes history as fixed
effects, and participant as a random effect.
3. A reduced model with the orderof measurement and
any significant covariates from the full model
included as fixed effects, and participant as a
random effect.
Maximum likelihoods estimation was used for the model
development, the appropriateness of the reduced model
selection was based on the Akaike Information Criterion
(AIC), a goodness of fit statistic that takes account of the
change in the deviance and penalises the model fit for the
inclusion of extra parameters (38). Markov Chain Monte
Carlo (MCMC) methods were used to estimate the
posterior density based on the fitted model, and hence
the significance of the fixed effects (39). The 95% highest
probability densities (95%HPD) and the test of signifi-
cance were both estimated using this approach.
All analyses and graphs were created within the R
statistical environment (40). The lme4 package was used
for the linear mixed modelling (41).
Ethics
The study protocol was reviewed and approved by the
Monash University Human Research Ethics Committee
(approval number: CF11/0583  2011000263). All parti-
cipants provided informed consent.
Results
Summary results for the diastolic and (untransformed)
systolic readings are shown in Table 1.
The average systolic blood pressure of the participants
( 127 mmHg) was consistent with the classification of
prehypertensive in a clinical setting, and the average
diastolic blood pressure, depending on the timing and
the device/operator used, was generally consistent with a
classification of blood pressure in the desirable range (42).
There were broad points of similarity and difference
between the measures. With respect to the systolic
maximum and minimum values, the mercury devices
(i.e. operated by qualified health workers) have lower
values than the electronic devices (i.e. operated by non-
health workers), but all have similar means and medians.
With respect to the diastolic values, the electronic devices
record lower mean and median values than the mercury
devices (around 5 mmHg), and also recorded lower
maximum values.
BlandAltman plots show the difference between two
measures against the average value of the two measures
(Fig. 1a and b) (36). ‘Agreement’ is related to both the
mean difference between the readings on the two devices,
and the amount of variation in the differences.
Figure 1a shows four BlandAltman plots for the
measures of systolic blood pressure: the mercury device
(Time 1) against the electronic device (Time 2) and
against the mercury device (Time 3), as well as the
electronic device (Time 2) against the electronic device
(Time 4). There are, thus, comparisons of similar devices
with each other, and comparisons of different devices at
adjacent times. The solid horizontal line indicates the
mean difference between the blood pressure readings for
the two comparison devices. The dashed horizontal lines
show the 95% limits of agreement around the mean
difference.
It is immediately apparent the mean differences
between the devices were all close to zero; i.e. on average,
the difference between the readings of the two deviceswas
close to zero. The 95% limits of agreement (i.e. the
variation in the differences) were narrowest for the
comparison of the two electronic devices (95%LA: 1.19
16 mmHg), and the widest limits of agreement occurred
for the comparison of the mercury device (T3) and the
electronic device (T4) (95%LA: 2.1924 mmHg).
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blood pressure. The mean differences were closest when
comparing identical types of device (1.7 and 1.1 mmHg)
than comparing across device type (5 and 5.6 mmHg).
The two electronic devices showed the strongest agree-
ment (95%LA: 1.7910 mmHg). The comparison of the
two mercury devices showed a marginally lower mean
difference, but wider 95% limits of agreement (95%LA:
1.1916 mmHg). The comparison of the mercury device
(T3) and the electronic device (T4) had a comparatively
large mean difference but relatively narrow limits of
agreement (95%LA: 5.6910 mmHg). The comparison of
the mercury device (T1) and the electronic device (T2)
showed a similar mean difference but much wider limits
of agreement (95%LA: 5916 mmHg).
By examining the cumulative proportion of blood
pressure measurements that differ by no more than a
given amount, one can gain a clearer sense of the
reliability (though not the validity) of the measures.
Fig. 2 shows an ogive of the absolute differences in blood
pressure measurements between: the mercury device
(Time 1) and the electronic device (Time 2), the two
mercury devices (Time 1 and Time 3), and the two
electronic devices (Time 2 and Time 4), for both systolic
and diastolic blood pressure. A Lowess curve was used to
smooth out the point-to-point variation and provide a
visual interpolation of the ogives. For almost any
proportion of blood pressure measurements, the varia-
tion was less between the two electronic devices (Time 2
and Time 4) than for any other combination of device.
Ninety percent of the electronic devices systolic blood
pressure readings had a difference of no more than 13
mmHg (Time 2 and Time 4), while the two mercury
devices measured systolic blood pressure had a difference
of no more than 18 mmHg (Time 1 and Time 3)  almost
exactly the same as for the difference between the first
mercury device and the first electronic device (Time 1 and
Time 3). A similar pattern was observed for diastolic
blood pressure readings, except that the absolute differ-
ences were consistently higher for the first mercury device
and the first electronic device (Time 1 and Time 3) than
for the two mercury devices (Time 1 and Time 3).
The repeated bloodpressure measureswithin individual
participants, the order of measurement, and the possible
effectsofcovariatessuchasparticipants’ageandsexmake
it difficult to obtain a complete picture of the relationship
between the readings obtained from the mercury and
electronic devices. A linear, mixed effects model was used
to manage the repeated measurements, the order of
measurement (type of device operator combination), and
the individual participants’ covariates. The analysis of
systolic blood pressure used log-transformed data.
Unsurprisingly, there was substantial clustering of the
blood pressure readings among participants (systolic
ICC0.86; diastolic ICC0.76). Table 2 shows the
results for the null (unconditional means), full (order of
measurement and covariates) and reduced (order of
measurement, and significant covariates) models. The
parameter estimates for the fixed effects, the AIC, and the
variance components are shown.
For the (log) systolic model, there was little difference
between the fixed effects estimates in the full and the
reduced models; however, the reduced model provided a
better fit to the data than the full model: AIC of 441 in
the full model versus 446 in the reduced model. The only
significant covariate was age. The order of testing, and by
extension the type of device, showed no significant
difference in the readings obtained by non-health workers
using electronic devices and health workers using mercury
devices. The average systolic reading for the base parti-
cipant (male, aged 49, at Time 1) was around 122 mmHg
(i.e. e
4.8 mmHg). Keeping the base participant in mind,
Table 1. Summary statistic for systolic and diastolic blood pressure in mmHg, measured with mercury and electronic devices at
four different times (T1T4)
Measure
Summary statistic
Max Min Median Mean SD n
Systolic
Mercury (T1) 181 89 124 128 22 55
Electronic (T2) 193 99 125 127 21 55
Mercury (T3) 177 92 127 124 19 54
Electronic (T4) 200 95 125 126 22 54
Diastolic
Mercury (T1) 111 50 80 81 13 55
Electronic (T2) 98 58 75 75 10 55
Mercury (T3) 100 56 79 79 11 54
Electronic (T4) 95 55 74 73 10 54
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of the 95%HPD) associated with a non-health worker
using an electronic device (Time 4) was 6 mmHg (e
4.80.047
mmHg), which was slightly less than the greatest likely
variation associated with the second reading by a health
professional using a mercury device (Time 3).
The pattern was somewhat different for the diastolic,
reduced, model. Like the systolic model, age was the only
(a)
(b)
Fig. 1. BlandAltman plots of the blood pressure differences between each possible pair of device-operator combination: (a)
diastolic pressure and (b) systolic pressure. The solid horizontal line indicates the mean difference between the measures, the
dashed horizontal lines indicate the 95% limits of agreement.
Community BP measurement by non-health workers
Citation: Glob Health Action 2012, 5: 14876 - http://dx.doi.org/10.3402/gha.v5i0.14876 5
(page number not for citation purpose)significant covariate. On the other hand, electronic
devices operated by non-health workers resulted in, on
average, a significantly lower average diastolic reading
than the mercury devices operated by medical practi-
tioners: between 5 (Time 2) and 7 (Time 4) mmHg lower.
The reduced model provided a better fit to the data than
the full model: AIC of 1480 in the full model versus 1477
in the reduced model. The average diastolic reading for
the base participant (male, aged 49, at Time 1) was
around 80 mmHg. Keeping the base participant in mind,
the greatest likely variation in blood pressure reading (i.e.
at the limit of the 95%HPD) associated with a non-health
worker using an electronic device (Time 4) was 10 mmHg.
Discussion
Community based, population research and screening
that involves blood pressure monitoring will be an
increasingly important part of any non-communicable
diseases strategy, and valid, reliable and cost-effective
methods of measurement will be required. The results
from this study, the first to validate blood pressure
measurement by non-health workers in a community
setting, suggest that with an electronic blood pressure
measurement device and a little training, non-health
workers may provide a suitable alternative to qualified
health workers. Although, the diastolic blood pressure
measurements taken by non-health workers using
electronic devices were on average lower (7 mmHg)
than measurements taken by health workers, the differ-
ence was within reasonable bounds. Furthermore, inde-
pendent readings by two different non-health workers
showed less variation, that is greater agreement, than did
two independent readings by the qualified health workers.
There was no significant difference in systolic blood
pressure taken by non-health workers using an electronic
device and health workers using a mercury sphygmoman-
ometer; and, again, independent readings by two different
non-health workers showed greater agreement, than did
two independent readings by health workers.
The findings are, broadly consistent with the validation
literature on the use of electronic blood pressure devices
in clinical settings, and should reassure readers of the
validity (although untested at the time) of those earlier
studies that used non-health workers taking blood
pressure measurements in community settings (2025).
One should bear in mind, however, that the kind of
agreement in clinical validation studies that is achievable
with the simultaneous measurement of blood pressure at
a single point in time will always outperform the levels of
agreement achievable with serial measurements.
There are, nonetheless, some issues with the findings,
and they need to be interpreted within context.
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Fig. 2. Ogives showing the proportion (y-axis) of blood pressure measures with an absolute difference of no more than a certain
pressure (x-axis) for three of the four possible pairs of device-operator combinations.
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opportunity to obtain a gold standard (invasive) measure
of blood pressure, andwe are currently reliant on the gold
standard for the indirect, non-invasive, measurement of
blood pressure  a health worker with a mercury
sphygmomanometer (13). Given the variability in the
measurements by the medical practitioners, however, the
extent to which this is a reasonable gold standard in a
community-based setting is moot. It is also known, for
instance that individual blood pressure can vary substan-
tially, and clinical measurements (where the gold stan-
dard is applied) correlate poorly with measurements
taken in the community (33, 43). The difference, however,
is not simply an artefact of mis-measurement; it is also an
artefact of genuine variation in individual blood pressure
across settings. This is one of the challenges of imple-
mentation research, where one is moving out of clinical
environments into ‘real world’ settings which necessarily
involve a loss of experimental and/or clinical control (44).
This study was relatively small; it relied on a handful of
non-health workers, a handful of health practitioners,
and only one model of electronic sphygmomanometer.
The study was also community-based and not home-
based. Replication studies in different populations and
different field settings with different devices are war-
ranted. Notwithstanding this, given the cost of the
devices and the relatively cheap labour costs associated
with non-health workers, the evidence would appear to
support the adoption for community-based, population
health research. Cost effectiveness studies would be
particularly useful in determining this.
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Table 2. The null, full and reduced, mixed-effects linear models of blood pressure measurement
Null Full Reduced
Estimate 95%HPD Estimate 95%HPD Estimate 95%HPD
Systolic models
Time 2 (electronic) 0.002 .038 to 0.029 0.002 0.04 to 0.028
Time 3 (mercury) 0.026 0.062 to 0.006 0.027 0.061 to 0.007
Time 4 (electronic) 0.011 0.045 to 0.022 0.01 0.047 to 0.02
Age (centre49) 0.006* 0.004 to 0.008 0.005*** 0.004 to 0.007
Sex (female) 0.012 0.062 to 0.033
Diabetes (yes) 0.006 0.057 to 0.049
Hypertension (yes) 0.038 0.090 to 0.026
Intercept 4.8*** 4.804.85 4.9*** 4.864.91 4.8*** 4.814.87
AIC 428.8 441 446.4
s
2 Person (level 2) 0.022 0.016 0.016
s
2 Resid 0.003 0.003 0.003
Diastolic models
Time 2 (electronic) 5.1*** 8.1 to 2.7 5.1*** 2.9 to 8.1
Time 3 (mercury) 1.2 4.2 to 1.2 1.2 4.3 to 1.1
Time 4 (electronic) 6.8*** 7.1 to 9.9 6.8*** 10.0 to 4.6
Age (centre49) 0.3*** 0.10.3 0.2* 0.09
Sex (female) 3.3 7.1 to 0.5
Diabetes (yes) 1.4 2.4 to 5.7
Hypertension (yes) 4.3 8.5 to 0.5
Intercept 77.0*** 74.976.8 83.6*** 78.282.9 80.4*** 80.480.5
AIC 1533 1480 1477
s
2 Person (level 2) 105.1 91.6 96.2
s
2 Resid 33.2 23.2 23.2
*pB0.05, ***pB0.001 based on MCMC estimation.
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